医学 >>> 临床医学 >>> 内科学 >>> 心血管病学 呼吸病学 结核病学 胃肠病学 血液病学 肾脏病学 内分泌学 风湿病学与自体免疫病学 变态反应学 感染性疾病学 内科学其他学科
搜索结果: 1-11 共查到内科学 Transplant相关记录11条 . 查询时间(0.062 秒)
Background: Low plasma concentrations of pyridoxal 5′-phosphate (PLP) are common in renal transplant recipients (RTRs) and confer increased risk of long-term mortality. To our knowledge, it is not kno...
Background: Previous studies have reported low circulating concentrations of pyridoxal-5-phospate (PLP) in renal transplant recipients (RTRs). It is unknown whether this is because of low intake or al...
Background: Renal transplant recipients (RTRs) have commonly been urged to limit their potassium intake during renal insufficiency and may adhere to this principle after transplantation. Importantly, ...
Background: There is evidence that renal transplant recipients have accelerated atherosclerosis that is manifest by increased cardiovascular morbidity and mortality. The high incidence of atherosclero...
中国医学科学院实验血液学国家重点实验室韩忠朝课题组在Cell Transplant期刊上发表"Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis."
A Medical Research Council (MRC) supported study has identified a ‘full set’ of immunological markers in the blood, which could be used to predict whether an individual’s kidney transplant will be a l...
Urinary tract infection (UTI) is considered as one of the important bacterial infections seen among renal transplant recipients. In the present study, bacterial urinary tract infections in renal trans...
Background: Human cytomegalovirus (HCMV) has been an enormous threat for bone marrow transplant (BMT) recipients. For active and/or latent HCMV infection, diagnosis of the risk factors which increase ...
In March 2002, a 48-year-old male patient was admitted due to left lower abdominal discomfort and fever. His past medical history included end-stage renal disease due to chronic glomerulonephritis. In...
Background: Post-transplant diabetes mellitus (PTDM) contributes to the risk for cardiovascular diseases and infection, reducing graft and patient survival. This study was conducted to identify the in...
April 6, 2007,The U.S. Food and Drug Administration (FDA) today announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is the...

中国研究生教育排行榜-

正在加载...

中国学术期刊排行榜-

正在加载...

世界大学科研机构排行榜-

正在加载...

中国大学排行榜-

正在加载...

人 物-

正在加载...

课 件-

正在加载...

视听资料-

正在加载...

研招资料 -

正在加载...

知识要闻-

正在加载...

国际动态-

正在加载...

会议中心-

正在加载...

学术指南-

正在加载...

学术站点-

正在加载...